Measuring success: Cost-effectiveness and expanding access to cochlear implantation

Otology and Neurotology

Volumn 37, Issue 2, 2016, Pages e135-e140

  Saunders, James E ^a   Francis, Howard W ^b   Skarzynski, Piotr H ^c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cochlear implants; Cost effectiveness; DALY; Developing countries; QALY

Indexed keywords

COCHLEA PROSTHESIS; COCHLEAR IMPLANTATION; COST BENEFIT ANALYSIS; ECONOMICS; HEARING LOSS, SENSORINEURAL; HUMAN; PROCEDURES; QUALITY OF LIFE;

COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; COST-BENEFIT ANALYSIS; HEARING LOSS, SENSORINEURAL; HUMANS; QUALITY OF LIFE;

EID: 84957879519     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000942     Document Type: Conference Paper

References (40)

1. Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: A call to action. Bull World Health Organ 2014;92:367-73.
2. Stevens G, Flaxman S, Brunskill E, et al., Global Burden of Disease Hearing Loss Expert Group. Global and regional hearing impairment prevalence: An analysis of 42 studies in 29 countries. Eur J Public Health 2013;23:146-52.
3. Saunders JE, Vaz S, Greinwald JH, et al. Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope 2007;117: 387-98.
4. Edejer TTT, Baltussin R, Adam T, et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, Switzerland: World Health Organization Press; 2003.
5. Gold MR, Stevenson D, Fryback DG. HALYS and QALYS and DALYS, Oh My: Similarities and differences in summary measures of population Health. Annu Rev Public Health 2002;23:115-34.
6. Baltussen R, Niessen L. Priority setting of health interventions: The need for multi-criteria decision analysis. Cost Eff Resour Alloc 2006;4:14.
7. Bond M, Mealing S, Anderson R, et al. The effectiveness and costeffectiveness of cochlear implants for severe to profound deafness in children and adults: A systematic review and economic model. Health Technol Assess 2009;13:1-330.
8. Klarman HE. Application of cost-benefit analysis to health systems technology. J Occup Med 1974;16:172-86.
9. Cheng AK, Rubin HR, Powe NR, et al. Cost-utility analysis of the cochlear implant in children. JAMA 2000;284:850-6.
10. Turchetti G, Bellelli S, Palia I, et al. Systemic review of the scientific literature of the economic evaluation of cochlear implants in adult patients. Acta Otorhinolaryngol Ital 2011;31: 319-27.
11. Ugalde A, Jackson JT. The World Bank and international health policy: A critical review. J Int Dev 1995;7:525-41.
12. Grosse SD, Lollar DJ, Campbell VA, et al. Disability and disabilityadjusted life years: Not the same. Public Health Rep 2009;124: 197-202.
13. McKenna MT, Michaud CM, Murray CJ, et al. Assessing the burden of disease in the United States using disability-Adjusted life years. Am J Prev Med 2005;28:415-23.
14. Longfield K, Smith B, Gray R, et al. Putting health metrics into practice: Using the disability-Adjusted life year for strategic decision making. BMC Public Health 2013;13 (Suppl 2):S2.
15. Chisholm D, Baltussen R, Evans DB, et al. What are the priorities for prevention and control of non-communicable diseases and injuries in sub-Saharan Africa and South East Asia? BMJ 2012;344:e586.
16. Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels and burden of disease. PLoS One 2011;6:e16837.
17. Shroufi A1, Chowdhury R, Aston LM, et al. Measuring health: A practical challenge with a philosophical solution? Maturitas 2011;68:210-6.
18. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
19. Vos et al. (Global Burden of Disease Study 2013 Collaborators). Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
20. Murray CJ et al. [GBD 2013 DALYs and HALE Collaborators] Global, regional, and national disability-Adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition. Lancet 2015. doi: 10.1016/S0140-6736(15)61340-X. [Epub ahead of print].
21. Mathers C, Boerma T, Ma Fat D, et al. The Global Burden of Disease: 2004 Update. WHO Library Catalogue. World Health Organization: Geneva Switzerland; 2008.
22. Werngren-Elgström M, Dehlin O, Iwarsson S. Aspects of quality of life in persons with pre-lingual deafness using sign language: Subjective wellbeing, ill-health symptoms, depression and insomnia. Arch Gerontol Geriatr 2003;37:13-24.
23. Keilmann A, Limberger A, Mann WJ. Psychological and physical well-being in hearing-impaired children. Int J Pediatr Otorhinolaryngol 2007;71:1747-52.
24. Fellinger J, Holzinger D, Sattel H, et al. Mental health and quality of life in deaf pupils. Eur Child Adolesc Psychiatry 2008;17:414-23.
25. Meyer A, Sie K, Skalicky A, et al. Quality of life in youth with severe to profound sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg 2013;139:294-300.
26. Meserole RL, Carson CM, Riley AW, et al. Assessment of healthrelated quality of life 6 years after childhood CI. Qual Life Res 2014;23:719-31.
27. ONeill C, ODonoghue GM, Archbold SM, et al. A cost-utility analysis of pediatric CI. Laryngoscope 2000;110:156-60.
28. Schulze-Gattermann H, Schoenermark M, Lenarz T, et al. Costbenefit analysis of pediatric CI: German experience. Otol Neurotol 2002;23:674-81.
29. Barton GR, Stacey PC, Fortnum HM, et al. Hearing-impaired children in the United Kingdom, IV: Cost-effectiveness of pediatric CI. Ear Hear 2006;27:575-88.
30. Molinier L, Bocquet H, Bongard V, et al. The economics of cochlear implant management in France: A multicenter analysis. Eur J Health Econ 2009;10:347-55.
31. Geers AE, Strube MJ, Tobey EA, et al. Epilogue: Factors contributing to long-Term outcomes of CI in early childhood. Ear Hear 2011;32 (1 Suppl):84S-92S.
32. Saunders JE, Barrs D, Wilson B, et al. Cost Effectiveness of Childhood Cochlear Implantation and Deaf Education in Nicaragua. Otol Neurotol 2015;36:1349-56.
33. Susan D, Emmett SD, Tucci DL, et al. GDP Matters: Cost Effectiveness of Cochlear Implantation and Deaf Education in Sub-Saharan Africa. Otol Neurotol 2015;36:1357-65.
34. An SK, Park SI, Jun SB, et al. Design for a simplified cochlear implant system. IEEE Trans Biomed Eng 2007;54 (6 Pt 1): 973-82.
35. An SK, Park SI, Jun SB, et al. Design for a simplified cochlear implant system. IEEE Trans Biomed Eng 2007;54 (6 Pt 1):973-82.
36. Zeng FG. Cochlear implants in China. Audiology 1995;34:61-75.
37. Ramos A, Rodriguez C, Martinez-Beneyto P, et al. Use of telemedicine in the remote programming of cochlear implants. Acta Otolaryngol 2009;129:533-40.
38. McElveen JT Jr, Blackburn EL, Green JD Jr, et al. Remote programming of cochlear implants: A telecommunications model. Otol Neurotol 2010;31:1035-40.
39. Skarzynski PH, Pilka A, Ludwikowski M, et al. Comparison of the frequency of positive hearing screening outcomes in schoolchildren from Poland and other countries of Europe, Central Asia. J Hear Sci 2014;4:51-8.
40. Skarzynski PH, Swierniak W, Pilka A, et al. Pilot hearing screening program in children from primary schools in Tajikistan. Now Audiofonol 2013;2:42-7.